CDC42BPA::BRAF represents a novel fusion in desmoplastic infantile ganglioglioma/desmoplastic infantile astrocytoma

Neurooncol Adv. 2024 Mar 30;6(1):vdae050. doi: 10.1093/noajnl/vdae050. eCollection 2024 Jan-Dec.
No abstract available

Keywords: CDC42BPA (MRCK) gene alteration; MAPK pathway activation and inhibition; desmoplastic infantile astrocytoma; novel CDC42BPA::BRAF fusion.